Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 14, 2015

View Archived Issues

Polyphor to use eFlow nebulizer to deliver POL-6014 for rare lung diseases

Novartis begins phase I/II study of FGF-401 in adults with solid malignancies

Enrollment open in phase II trial of OTL-38 imaging agent for ovarian cancer

Isis and Alnylam extend 2004 strategic partnership on RNA therapeutics

Incyte and Agenus to develop novel immune-oncology antibodies

Sage Therapeutics updates data on SAGE-547 for super-refractory status epilepticus

Arena initiates phase II trial of ralinepag for pulmonary arterial hypertension

Debiopharm regains rights to alisporivir from Novartis

New vasopressin V1A receptor antagonist found to influence social cognition

BioMarin reports interim data from phase I/II study of BMN-190 for CLN2 disease

Bench-side progress towards novel therapies for myeloid tumors

WuXi PharmaTech acquires NextCODE Health

Roche obtains rights to Meiji's beta-lactamase inhibitor OP-0595

Alere completes sale of healthcare services division to Optum

X-Chem and Janssen Biotech form anti-inflammatory drug discovery collaboration

Scynexis' SCY-078 receives FDA fast track designation for oral treatment of fungal infections

Arylquin-1, a Par-4 secretatogue with a novel mechanism of action

Yakult Honsha patent details novel platinum complex for cancer

Merck & Co. reports development of compounds for HCV infections

Asana BioSciences researchers prepare immunofusion molecules for cancer

Boehringer Ingelheim patent divulges novel AMPK activators

AB Science patents new SCFR inhibitors

Auspex to obtain remaining rights to SD-1077 through acquisition of Imphar

Zydus begins phase III study of saroglitazar in NASH

EMA grants positive opinion for orphan drug status for enadenotucirev

Lung Therapeutics' LTI-01 granted orphan drug designation in the E.U.

Novel biomarker associated with MDD

AbbVie and Neurocrine's elagolix reduces endometriosis pain in phase III trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...